Biobanking of Exosomes in the Era of Precision Medicine: Are We There Yet?

The emerge of personalized medicine demands high-quality human biospecimens with appropriate clinical annotation, especially in complex diseases such as cancer, neurodegenerative, cardiovascular, and metabolic alterations in which specimen heterogeneity and individual responses often complicate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora, Edna M., Álvarez-Cubela, Silvia, Oltra, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730260/
https://www.ncbi.nlm.nih.gov/pubmed/26712742
http://dx.doi.org/10.3390/ijms17010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730260/
https://www.ncbi.nlm.nih.gov/pubmed/26712742
http://dx.doi.org/10.3390/ijms17010013

Ejemplares similares